glp 1 medications pros and cons 2026 Employee Benefits Trends: Should You Cover GLP‑1s for Weight Loss? The Benefits of GLP-1 Therapy:
Description
AnaptysBio is developing its own wholly owned PD-1 agonist candidate for rheumatoid arthritis, rosnilimab, with data expected in Q1 2025
Some stimulant laxatives are best used short term
CDC data show rising GLP-1 use as part of diabetes therapy, reflecting guideline adoption
This highlights the dual role these drugs play in managing both blood sugar and weight
Niu C, Kefang S, Jing Z, et al
Advertising must have competent and reliable scientific evidence
